How it works
Generic thresholds fire too often for the elderly and not often enough for the chronically ill. VitalSentry's anomaly engine learns one person's normal — then watches for the small drifts that precede the big event.
A small hub pairs with the patient's existing wearables. No new habits to learn, no screen to manage.
The first two weeks train a personal model — baseline vitals, normal sleep, normal routine — for one specific person.
Each new reading is scored against that baseline. Subtle changes (a creeping resting heart rate, missed doses three days running) surface as alerts.
Family gets a quiet daily digest. Clinicians get the longitudinal context. A real anomaly pages the on-call nurse within seconds.
What the system watches
The same patient, watched through three lenses at once. When two of them agree, someone hears about it.
Heart rate, SpO₂, blood pressure trends, and weight logged passively from wearables the patient already wears.
Each scheduled dose reconciled against confirmed pickup and intake — missed doses flagged within minutes.
In-home sensors surface falls, restless sleep, and shifts in routine before a crisis becomes a 911 call.
Who it’s for
The same platform, three very different front doors — each built around who is reading and what decision they’re about to make.
A daily digest tells you mom is fine — and a quiet alert if she’s not. Your phone isn’t a monitor; it’s a brief.
Wednesday digest
All quiet on Eleanor’s front.
Resting HR up 4 bpm since Sunday — within personal range. Sleep slightly lighter; no cause for concern. Both meds taken within the agreed window.
Pricing
Hardware is included. Contracts are month-to-month. You can cancel from a real human, not a dropdown.
For one loved one at home
$39 / month
Home health & senior living
From $24 / patient
For care teams & ACOs
On request
End-to-end encryption, role-scoped access, per-patient audit logs, and a data residency option for EU and Canadian deployments. We are HIPAA-aligned, SOC 2 Type II in progress, and we never sell or aggregate health data.
In a 12-month, 1,200-patient pilot across three Medicare Advantage plans, VitalSentry’s care-pathway participants saw a 28% drop in CHF-related readmissions and a 41% improvement in medication-on-time rates. Detailed whitepaper available on request.
Get in touch
Tell us a little about who you’re caring for, and we’ll send a plain-spoken guide — no sales call required.
A real human reads it — usually within a few hours, every day of the week.